# ARL Biopharma, Inc. – FDA Inspection, Sep 20, 2019

Source: https://www.keypedia.com/records/fda_inspections/arl-biopharma-inc/00b13fc7-baf0-4864-922b-b9359c7c19bc
Source feed: FDA_Inspections

> FDA inspection 1102393 of ARL Biopharma, Inc., September 20, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102393
- Company Name: ARL Biopharma, Inc.
- Inspection Date: 2019-09-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1322550 - 2026-05-22
- [FDA Inspection 965921 - 2016-03-25](https://www.keypedia.com/records/fda_inspections/arl-biopharma-inc/d5a8ac1d-9744-43f0-a76e-6727f2380fa5)
- FDA Inspection 806356 - 2012-11-08
- FDA Inspection 701726 - 2010-11-19
- FDA Inspection 651237 - 2010-02-18

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)

Company: https://www.keypedia.com/companies/arl-biopharma-inc/358f0af9-fe47-4cd8-b43e-a4b9eacf1b21

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c